Guide on access to unpublished documents

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 April 2024, 10:00 (CEST) to 10 April 2024, 12:30 (CEST)

Agenda - Joint HMA/EMA Big Data Steering Group Workshop on RWE methods

Human medicines European public assessment report (EPAR): Sifrol, pramipexole, Date of authorisation: 13/10/1997, Revision: 39, Status: Authorised

List of eligible industry stakeholder organisations

Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 10, Status: Authorised

Agenda - Fourth EMA-AESGP bilateral meeting

Minimum inhibitory concentration (MIC) breakpoints

Minimum inhibitory concentration (MIC) breakpoints

Psychedelics and their therapeutic use - Linkedin Live interview with Steffen Thirstrup, EMA's Chief Medical Officer, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 May 2024, 11:30 (CEST) to 7 May 2024, 12:00 (CEST)